These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 14563183

  • 1. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G.
    Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 3. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Townsend CM, Parker CE, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Oct 26; 10(10):CD000545. PubMed ID: 27783843
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M.
    N Engl J Med; 1995 Feb 02; 332(5):292-7. PubMed ID: 7816064
    [Abstract] [Full Text] [Related]

  • 5. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
    Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG, REACT Study Investigators.
    Lancet; 2015 Nov 07; 386(10006):1825-34. PubMed ID: 26342731
    [Abstract] [Full Text] [Related]

  • 6. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
    Schröder O, Blumenstein I, Stein J.
    Eur J Gastroenterol Hepatol; 2006 Jan 07; 18(1):11-6. PubMed ID: 16357613
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate for the treatment of refractory Crohn's disease.
    Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R.
    Aliment Pharmacol Ther; 1996 Jun 25; 10(3):309-14. PubMed ID: 8791956
    [Abstract] [Full Text] [Related]

  • 9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 10. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW.
    N Engl J Med; 2000 Jun 01; 342(22):1627-32. PubMed ID: 10833208
    [Abstract] [Full Text] [Related]

  • 11. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH.
    Gastroenterology; 1999 Sep 01; 117(3):527-35. PubMed ID: 10464128
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA, McDonald JW, Feagan BG.
    Cochrane Database Syst Rev; 2003 Sep 01; (1):CD003459. PubMed ID: 12535475
    [Abstract] [Full Text] [Related]

  • 13. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF, Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
    Gastroenterology; 2013 Oct 01; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [Abstract] [Full Text] [Related]

  • 14. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R.
    Gut; 1995 Nov 01; 37(5):674-8. PubMed ID: 8549944
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V, Macdonald JK, McDonald JW, Chande N.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390
    [Abstract] [Full Text] [Related]

  • 16. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA, Petritsch W, Aichbichler B, Fickert P, Ranner G, Krejs GJ.
    Z Gastroenterol; 1997 Aug 07; 35(8):603-8. PubMed ID: 9297775
    [Abstract] [Full Text] [Related]

  • 17. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C, Wittig BM, Moser C, Zeitz M, Stallmach A.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):343-50. PubMed ID: 16842461
    [Abstract] [Full Text] [Related]

  • 18. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J, López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M, AZTEC Study Group.
    Gastroenterology; 2013 Oct 15; 145(4):766-74.e1. PubMed ID: 23770132
    [Abstract] [Full Text] [Related]

  • 19. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E, Beau P.
    Gastroenterol Clin Biol; 2002 Apr 15; 26(4):367-71. PubMed ID: 12070412
    [Abstract] [Full Text] [Related]

  • 20. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
    Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Büschenfelde KH, Schlaak JF.
    Gut; 1999 May 15; 44(5):625-8. PubMed ID: 10205197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.